Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02454803 · ClinicalTrials.gov registry record
Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice
A clinical trial, sponsored by Ipsen.
- Completed
- Registry status
- 1,004
- Enrollment target
NCT02454803 is a clinical trial that has completed, run by Ipsen. The registered enrollment target is 1,004 participants.
The verdict
NCT02454803 has completed, sponsored by Ipsen.
- COMPLETED
- Registry status
- 1,004 participants
- Enrollment target
Study Summary
The primary purpose for this study is to understand the effect of botulinum toxin as a treatment integrated in the management of spasticity (stiffness) in the arm and/or hand, arising from any neurological condition. The study will look at the types of goals that people choose for treatment, and the extent to which these are achieved in different individuals.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,004 participants |
| Start Date | 2015-01 |
| Est. Completion | 2019-06-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02454803
The ClinicalTrials.gov registry entry for NCT02454803 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,004 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ipsen, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02454803 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02454803 about?
NCT02454803 is a clinical study titled "Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice". The primary purpose for this study is to understand the effect of botulinum toxin as a treatment integrated in the management of spasticity (stiffness) in the arm and/or hand, arising from any neurological condition. The study will look at the types of goals that people choose for treatment, and the...
What is the current status of trial NCT02454803?
This trial is currently completed. The enrollment target is 1,004 participants. The study started on 2015-01. Estimated completion is 2019-06-03.
Who is sponsoring clinical trial NCT02454803?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.